Occlutech

Occlutech is a global leader in minimally invasive structural heart disease devices, with a customer support and supply hub in Helsingborg. The company develops, manufactures, and sells implants for congenital heart defects (ASD/PFO), stroke prevention (LAA), and heart failure (interatrial shunts), with over 135,000 products implanted in approximately 85 countries. Occlutech employs around 250 people globally and has R&D and manufacturing in Jena, Germany and Istanbul, Turkey.